Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-23-000695
Filing Date
2023-05-15
Accepted
2023-05-15 14:41:13
Documents
66
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q opgn-20230331.htm   iXBRL 10-Q 730076
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 7552
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 7573
4 EXHIBIT 32.1 ex32x1.htm EX-32.1 4485
  Complete submission text file 0001079973-23-000695.txt   5809082

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE opgn-20230331.xsd EX-101.SCH 81077
6 XBRL CALCULATION FILE opgn-20230331_cal.xml EX-101.CAL 53270
7 XBRL DEFINITION FILE opgn-20230331_def.xml EX-101.DEF 336291
8 XBRL LABEL FILE opgn-20230331_lab.xml EX-101.LAB 651509
9 XBRL PRESENTATION FILE opgn-20230331_pre.xml EX-101.PRE 344677
60 EXTRACTED XBRL INSTANCE DOCUMENT opgn-20230331_htm.xml XML 633059
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

EIN.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37367 | Film No.: 23921066
SIC: 8071 Services-Medical Laboratories